Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02580058 |
|---|---|
| Brief Title: | A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) |
| First Submitted : | October 16, 2015 |
| First Submitted that Met QC Criteria : | October 16, 2015 |
| First Posted : | October 20, 2015 (Estimate) |
| Results First Submitted : | September 9, 2019 |
| Results First Submitted that Met QC Criteria : | November 1, 2019 |
| Results First Posted : | November 19, 2019 |
| Last Update Submitted that Met QC Criteria : | July 25, 2022 |
| Last Update Posted : | July 29, 2022 |